Where Does Wall Street Think Evelo Biosciences Inc (EVLO) Stock Will Go?

Wall Street is positive on Evelo Biosciences Inc (EVLO). On average, analysts give Evelo Biosciences Inc a Strong Buy rating. The average price target is $19.1, which means analysts expect the stock to increase by 712.77% over the next twelve months. That average ranking earns Evelo Biosciences Inc an Analyst Rating of 63, which is better than 63% of stocks based on data compiled by InvestorsObserver.

Wall Street analysts are rating EVLO a Strong Buy today. Find out what this means to you and get the rest of the rankings on EVLO!

See Full EVLO Report

Why are Analyst Ratings Important?

You can learn a lot about a company from looking at it’s financial statements and comparing them to other companies. Analysts who cover an industry in depth can add even more to your research though. They typically follow a particular sector or industry very closely. They also pay attention to and ask questions on earnings conference calls and other events where they might learn information that does show up in the numbers. InvestorsObserver takes the average rating from these analysts, and then percentile ranks those averages. This lets you compare stocks in a much more granular way than just seeing the typical five-tiered rating system used on most of Wall Street.

What's Happening With Evelo Biosciences Inc Stock Today?

Evelo Biosciences Inc (EVLO) stock is higher by 12.44% while the S&P 500 is down -1.16% as of 11:25 AM on Friday, Apr 22. EVLO is higher by $0.26 from the previous closing price of $2.09 on volume of 76,883 shares. Over the past year the S&P 500 has gained 5.03% while EVLO is down -78.94%. EVLO lost -$2.31 per share the over the last 12 months. Click Here to get the full Stock Report for Evelo Biosciences Inc stock.